XBiotech Statistics
NASDAQ: XBITHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.18-0.0098 (-0.45%)
Market open · Delayed 15 min · as of Oct 8, 3:12 PM ET
XBiotech by the numbers
XBiotech has a market capitalization of $66.5 million based on 30.49M shares outstanding. With trailing EPS of $-1.48, XBiotech is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.4% below its 50-day average and 7.7% below its 200-day average.
Average daily trading volume is 40.47K shares, or about $88,235 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
XBIT valuation vs. peer median
| Metric | XBIT | Peer median | Difference |
|---|---|---|---|
| Market cap | $66.47M | $66.39M | +0% |
| Avg. volume | 40.47K | 460.25K | -91% |
Peer median across 8 companies: SPRO, RNTX, HYFT, APLM, NMAD, FBIO, HRTX, PLRX.
Valuation
- Market cap
- $66.47M
- Forward P/E
- 16.77
- EPS (TTM)
- $-1.48
- Shares outstanding
- 30.49M
Price and trading
- Previous close
- 2.19
- Open
- 2.19
- Day range
- 2.15 – 2.22
- 52-week range
- 2.09 – 3.44
- 52-week change
- -17.05%
- Beta
- —
- Volume
- 11.96K
- Average volume
- 40.47K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2025
Additional statistics
- Market Cap
- 66.47M
- Forward Pe
- 16.77
- Eps
- -1.48
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.44
- Week52 Low
- 2.09
- Avg Volume
- 40,471.00
- Shares Outstanding
- 30.49M
- Ma50
- 2.23
- Ma200
- 2.36
- Earnings Date
- Aug 11, 2025
- Pct From52w High
- -36.62%
- Pct From52w Low
- 4.32%